The profit raise lost the argument
MOH was still down about 12% by mid-afternoon Thursday, even after Molina raised its 2026 adjusted earnings outlook by 25 cents to at least $5.25 a share.
The drop puts the focus on a larger change. Molina kept its 2026 premium revenue outlook at about $42 billion, but plans to remove roughly $1 billion of annual Marketplace premium revenue in 2027. The company expects to operate Marketplace plans in about six states, down from roughly 13 or 14.
A higher earnings floor helps the current year. A planned revenue retreat raises a tougher question about the business Molina will have left.
The guidance change came from at least $5.00 a share. It is a real increase, but the second quarter showed why investors may not see it as a clean recovery. Adjusted earnings fell 74% from a year earlier to $1.51 a share. GAAP net income dropped 76% to $60 million, while premium revenue declined 6% to $10.24 billion.
Those figures do not prove the state exit is the cause of Thursday’s decline. They do show that Molina is trying to improve earnings while its top line and profits are both under pressure. The key issue is whether the smaller Marketplace footprint removes a bad business or signals that the company cannot earn enough in a large part of that market.
Marketplace is erasing Medicare’s gain
Molina generated $4.49 billion of Marketplace premium revenue in 2025. Walking away from about $1 billion of annual revenue is therefore a meaningful reduction, not a small trim around the edges.
The reason sits in the medical care ratio. This measure shows how much of each premium dollar goes to medical claims, before administrative costs. Molina’s Marketplace medical care ratio was 88.9% in the second quarter, worse than management expected. Nearly 89 cents of every premium dollar went to claims before the company paid to run the business.
Pricing has not caught up with costs.
Management gave investors a useful earnings bridge. It said improvement in Medicare adds $1.50 a share, while deterioration in Marketplace subtracts $1.50 a share. The two changes cancel each other. Better results in one business are not yet flowing through to total earnings because Marketplace absorbs the benefit.
Molina also said that, excluding the Marketplace cut, its 2026 adjusted earnings outlook would have risen to $6.75 a share. That is $1.50 above the current floor, matching the Marketplace drag described by management. The figure is not a forecast that Marketplace will disappear as a problem. It is a measure of how much current Marketplace economics are weighing on earnings.
The favorable case is straightforward. Molina may be giving up low-quality revenue to stop losses, concentrate on better contracts, and preserve capital for Medicaid and Medicare. That could leave a smaller but healthier company.
The countercase is harder to dismiss. An exit from roughly half the states in a business that once produced billions in revenue may reflect a deeper problem with pricing, claims costs, or both. The remaining Marketplace states need to show better economics. Otherwise, the company may simply retain a smaller version of the same issue.
Medicaid now carries more of the burden
Molina served about 4.9 million members as of June 30. With Marketplace shrinking, Medicaid and Medicare will carry more weight in the earnings story.
Medicaid’s second-quarter medical care ratio was 92.7%, while Medicare’s was 90.7%. The two figures cannot be read as a direct ranking of profit because plan pricing and costs differ by program. Still, both show the narrow margin for error in businesses where claims costs must stay aligned with rates paid by government programs.
Medicare is improving, but Medicaid must stabilize too.
The company’s first-half operating cash flow swung to $788 million from a $112 million outflow a year earlier. That looks like a sharp improvement, but management said the change was driven mainly by the timing of government receivables and payables. It should not be treated as proof that operating margins have already recovered.
That distinction matters for the investment case. Cash flow based on payment timing can reverse. A lasting recovery needs better care ratios and rates that cover medical costs. Molina’s updated profit floor offers some evidence that management sees a path forward, but the unchanged revenue outlook and future Marketplace contraction show that path is narrow.
The next test is whether Medicaid rate increases translate into better margins without another reset to Molina’s revenue base. If care ratios improve while the company holds its remaining revenue base together, the Marketplace exit can look like disciplined repair. If claims costs stay ahead of rates, the $1 billion retreat will look less like a solution and more like the first sign of a longer earnings problem.
